Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Pulmatrix Inc (NASDAQ: PULM)

$2.89 USD $0.21 (7.84%)
Last Price $2.89
Net Change $0.21 (7.84%)
Bid $2.88
Ask Price $3
Open Price $2.68
Previous Close Price $2.68
High Price $3.02
Low Price $2.64
Number of Trades 2,356
Volume 1,373,955
Fifty Two Week High $6.98 (2017-02-02)
Fifty Two Week Low $0.5 (2016-12-30)
Average Daily Volume 4,492,429
Share Outstanding 17,930 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $0
Recent Earnings $
Annual EPS $-1.21
Last Quarter EPS $
Market Capitalization $0.05B
Insider Shareholders % 0.541%
Annual Revenue $0B
No. Shares Outstanding 17,930
Inst. Shareholder % 21.02%
Annual Net Income $0B
TTM Net Profit Margin $100.23
1-Year Return -21.41%
3-Year Return -84.62%
5-Year Return -85.21%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD %
Dividends per Share $
Stock Split Ratio 4-10
Beta 1.9
Pulmatrix, Inc. is a biopharmaceutical company which is engaged in developing inhaled therapies for serious pulmonary disease. The Company's proprietary product pipeline includes PUR1900, an inhaled anti-fungal for cystic fibrosis, PUR0200, a branded generic for chronic obstructive pulmonary disease which are in different clinical stage. Its technology platform consists of iSPERSE. Pulmatrix, Inc., formerly known as Ruthigen, Inc., is based in Lexington, MA.